[HTML][HTML] Genetic alterations in hepatocellular carcinoma: An update

ZS Niu, XJ Niu, WH Wang - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths
worldwide. Although recent advances in therapeutic approaches for treating HCC have …

Cell surface markers for mesenchymal stem cells related to the skeletal system: A scoping review

LN Fonseca, S Bolívar-Moná, T Agudelo, LD Beltrán… - Heliyon, 2023 - cell.com
Multipotent mesenchymal stromal cells (MSCs) have been described as bone marrow
stromal cells, which can form cartilage, bone or hematopoietic supportive stroma. In 2006 …

MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells

A Eirin, SM Riester, XY Zhu, H Tang, JM Evans… - Gene, 2014 - Elsevier
Mesenchymal stromal/stem cells (MSCs) are clinically useful for cell-based therapy, but
concerns regarding their ability to replicate limit their human application. MSCs release …

Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma

SG Swamy, VH Kameshwar, PB Shubha, CY Looi… - Targeted …, 2017 - Springer
Hepatocellular carcinoma (HCC) is one of the most common forms of liver cancer diagnosed
worldwide. HCC occurs due to chronic liver disease and is often diagnosed at advanced …

Curcumin suppresses doxorubicin-induced epithelial–mesenchymal transition via the inhibition of TGF-β and PI3K/AKT signaling pathways in triple-negative breast …

WC Chen, YA Lai, YC Lin, JW Ma… - Journal of agricultural …, 2013 - ACS Publications
Triple-negative breast cancer (TNBC) is defined by a lack of expression of the estrogen
receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor 2 (HER 2) …

[HTML][HTML] Molecular targeted therapy for hepatocellular carcinoma: current and future

JW Shin, YH Chung - World journal of gastroenterology: WJG, 2013 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most frequent tumors worldwide. The majority
of HCC cases occur in patients with chronic liver disease. Despite regular surveillance to …

Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy

Z Yin, K Jiang, R Li, C Dong, L Wang - Molecular Cancer, 2018 - Springer
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, with high
morbidity, relapse and mortality rates. Multipotent mesenchymal stromal cells (MSCs) can be …

Pharmacological modulation of beta‐catenin and its applications in cancer therapy

R Thakur, DP Mishra - Journal of cellular and molecular …, 2013 - Wiley Online Library
Abstract Beta‐catenin (β‐catenin) is a multifunction protein with a central role in
physiological homeostasis. Its abnormal expression leads to various diseases including …

Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma

YL Sha, S Liu, WW Yan, B Dong - Bioscience reports, 2019 - portlandpress.com
Hepatoblastoma is a malignant tumor in the liver of children that generally occurs at the age
of 2–3 years. There have been ample evidence from the preclinical as well as clinical …

Cysteine cathepsins: their biological and molecular significance in cancer stem cells

A Pišlar, A Jewett, J Kos - Seminars in cancer biology, 2018 - Elsevier
Cysteine cathepsins are lysosomal peptidases involved on one hand in general intracellular
protein degradation and, on the other, in the regulation of a number of specific physiological …